Cite
HARVARD Citation
Seino, Y. et al. (2022). A randomized trial to investigate the efficacy and safety of once‐daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg. Journal of diabetes investigation. 13 (8), pp. 1321-1329. [Online].